Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
22,328,924
-
Share change
-
+3,794,586
-
Total reported value
-
$4,565,328,716
-
Put/Call ratio
-
24%
-
Price per share
-
$204.43
-
Number of holders
-
215
-
Value change
-
+$828,204,827
-
Number of buys
-
142
-
Number of sells
-
59
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2019
As of 31 Dec 2019,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,328,924 shares.
The largest 10 holders included
CPMG Inc, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, Cormorant Asset Management, LP, STATE STREET CORP, Duquesne Family Office LLC, and FMR LLC.
This page lists
215
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.